Green coffee as a novel agent for Alzheimer's disease prevention by attenuating diabetes

Translational Neuroscience

Volumn 5, Issue 2, 2014, Pages 111-116

  Varghese, Merina ^a   Ho, Lap ^a,b   Wang, Jun ^a,b   Zhao, Wei ^a,b   Levine, Samara ^a   Ono, Kenjiro ^c   Mannino, Salvatore ^d   Pasinetti, Giulio Maria ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d Ospedale di Alzano Lombardo   (Italy)

Author keywords

Alzheimer's disease; Brain; Coffee; Diabetes; Diabetes type 2; Energy metabolism

Indexed keywords

AMYLOID BETA PROTEIN; ANTIDIABETIC AGENT; CAFFEINE; CHLOROGENIC ACID; GLUCOSE; NUCLEAR RESPIRATORY FACTOR; SVETOL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; COFFEE; DEMENTIA; DIABETES MELLITUS; DIETARY INTAKE; DRUG MECHANISM; FOOD COMPOSITION; GLUCOSE UTILIZATION; GREEN COFFEE; HUMAN; MENTAL PERFORMANCE; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION;

EID: 84903690396     PISSN: 20813856     EISSN: 20816936     Source Type: Journal    
DOI: 10.2478/s13380-014-0213-y     Document Type: Review

References (44)

1. International Diabetes Federation, IDF Diabetes Atlas, cited 2013 August 27, 5th Edition, 2012, available from: http://www.idf.org/diabetesatlas/5e/ Update2012
2. World Health Organization, Diabetes Fact Sheet, 1999, cited 2013 August 27, available from: http://www.who.int/mediacentre/factsheets/fs312/en/
3. Alberti K. G., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet. Med., 1998, 15, 539-553 (Pubitemid 28319935)
4. Vagelatos N. T., Eslick G. D., Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship, Epidemiol. Rev., 2013, 35, 152-160
5. Alzheimer's Association, 2013 Alzheimer's disease facts and figures, cited 2013 August 27, available from: http://www.alz.org/downloads/facts- figures-2013.pdf
6. Butt M. S., Sultan M. T., Cofee and its consumption: benefits and risks, Crit. Rev. Food Sci. Nutr., 2011, 51, 363-373
7. van Dam R. M., Hu F. B., Cofee consumption and risk of type 2 diabetes: a systematic review, JAMA, 2005, 294, 97-104 (Pubitemid 41002844)
8. Huxley R., Lee C. M., Barzi F., Timmermeister L., Czernichow S., Perkovic V., et al., Cofee, decafeinated cofee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis, Arch. Intern. Med., 2009, 169, 2053-2063
9. Muley A., Muley P., Shah M., Cofee to reduce risk of type 2 diabetes? A systematic review, Curr. Diabetes Rev., 2012, 8, 162-168
10. Reunanen A., Heliovaara M., Aho K., Cofee consumption and risk of type 2 diabetes mellitus, Lancet, 2003, 361, 702-703, author reply 703
11. Saremi A., Tulloch-Reid M., Knowler W. C., Cofee consumption and the incidence of type 2 diabetes, Diabetes Care, 2003, 26, 2211-2212
12. Floegel A., Pischon T., Bergmann M. M., Teucher B., Kaaks R., Boeing H., Cofee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) - Germany study, Am. J. Clin. Nutr., 2012, 95, 901-908
13. Pereira M. A., Parker E. D., Folsom A. R., Cofee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women, Arch. Intern. Med., 2006, 166, 1311-1316 (Pubitemid 43967585)
14. van Dam R. M., Willett W. C., Manson J. E., Hu F. B., Cofee, cafeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women, Diabetes Care, 2006, 29, 398-403 (Pubitemid 44106525)
15. Robinson L. E., Savani S., Battram D. S., McLaren D. H., Sathasivam P., Graham T. E., Cafeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes, J. Nutr., 2004, 134, 2528-2533 (Pubitemid 39315250)
16. Kogure A., Sakane N., Takakura Y., Umekawa T., Yoshioka K., Nishino H., et al., Effects of caffeine on the uncoupling protein family in obese yellow KK mice, Clin. Exp. Pharmacol. Physiol., 2002, 29, 391-394 (Pubitemid 34535358)
17. Yoshioka K., Yoshida T., Kamanaru K., Hiraoka N., Kondo M., (1990). Cafeine activates brown adipose tissue thermogenesis and metabolic rate in mice, J. Nutr. Sci. Vitaminol. (Tokyo), 1990, 36, 173-178 (Pubitemid 20327508)
18. Welsch C. A., Lachance P. A., Wasserman B. P., Dietary phenolic compounds: inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles, J. Nutr. 1989, 119, 1698-1704 (Pubitemid 20028920)
19. Hemmerle H., Burger H. J., Below P., Schubert G., Rippel R., Schindler P. W., et al., Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase, J. Med. Chem., 1997, 40, 137-145 (Pubitemid 27045071)
20. Prabhakar P. K., Doble M., Synergistic efect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes, Phytomedicine, 2009, 16, 1119-1126
21. Lee K. J., Jeong H. G., Protective efects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage, Toxicol. Lett., 2007, 173, 80-87 (Pubitemid 47371047)
22. Bakuradze T., Lang R., Hofmann T., Stiebitz H., Bytof G., Lantz I., et al., Antioxidant efectiveness of cofee extracts and selected constituents in cell-free systems and human colon cell lines, Mol. Nutr. Food Res., 2010, 54, 1734-1743
23. Hu N., Yu J. T., Tan L., Wang Y. L., Sun L., Nutrition and the risk of Alzheimer's disease, Biomed. Res. Int., 2013, 524820
24. Barranco Quintana J. L., Allam M. F., Del Castillo A. S., Navajas R. F. C., Alzheimer's disease and cofee: a quantitative review, Neurol. Res., 2007, 29, 91-95 (Pubitemid 46185076)
25. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G. B., et al., Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging, Am. J. Epidemiol., 2002, 156, 445-453 (Pubitemid 34976983)
26. Eskelinen M. H., Ngandu T., Tuomilehto J., Soininen H., Kivipelto M., Midlife cofee and tea drinking and the risk of late-life dementia: a population-based CAIDE study, J. Alzheimers Dis., 2009, 16, 85-91
27. Cao C., Loewenstein D. A., Lin X., Zhang C., Wang L., Duara R., et al., High blood cafeine levels in MCI linked to lack of progression to dementia, J. Alzheimers Dis., 2012, 30, 559-572
28. Cao C., Wang L., Lin X., Mamcarz M., Zhang C., Bai G., et al., Cafeine synergizes with another cofee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice, J. Alzheimers Dis., 2011, 25, 323-335
29. Gelber R. P., Petrovitch H., Masaki K. H., Ross G. W., White L. R., Coffee intake in midlife and risk of dementia and its neuropathologic correlates, J. Alzheimers Dis., 2011, 23, 607-615
30. Chu Y. F., Chang W. H., Black R. M., Liu J. R., Sompol P., Chen Y., et al., Crude cafeine reduces memory impairment and amyloid beta(1-42) levels in an Alzheimer's mouse model, Food Chem., 2012, 135, 2095-2102
31. Cao C., Cirrito J. R., Lin X., Wang L., Verges D. K., Dickson A., et al., Cafeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice, J. Alzheimers Dis., 2009, 17, 681-697
32. Arendash G. W., Mori T., Cao C., Mamcarz M., Runfeldt M., Dickson A., et al., Cafeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice, J. Alzheimers Dis., 2009, 17, 661-680
33. Arendash G. W., Schleif W., Rezai-Zadeh K., Jackson E. K., Zacharia L. C., Cracchiolo J. R., et al., Cafeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production, Neuroscience, 2006, 142, 941-952 (Pubitemid 44740473)
34. Fredholm B. B., Battig K., Holmen J., Nehlig A., Zvartau E. E., Actions of cafeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol. Rev., 1999, 51, 83-133 (Pubitemid 29113867)
35. Canas P. M., Porciuncula L. O., Cunha G. M., Silva C. G., Machado N. J., Oliveira J. M., et al., Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway, J. Neurosci., 2009, 29, 14741-14751
36. Angulo E., Casado V., Mallol J., Canela E. I., Vinals F., Ferrer I., et al., A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation, Brain Pathol., 2003, 13, 440-451 (Pubitemid 37420689)
37. Dostal V., Roberts C. M., Link C. D., Genetic mechanisms of cofee extract protection in a Caenorhabditis elegans model of betaamyloid peptide toxicity, Genetics, 2010, 186, 857-866
38. Evans M. J., Scarpulla R. C., Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences, J. Biol. Chem., 1989, 264, 14361-14368 (Pubitemid 19214267)
39. Trinh K., Andrews L., Krause J., Hanak T., Lee D., Gelb M., et al., Decafeinated cofee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism, J. Neurosci., 2010, 30, 5525-5532
40. Tohda C., Kuboyama T., Komatsu K., Search for natural products related to regeneration of the neuronal network, Neurosignals, 2005, 14, 34-45 (Pubitemid 40868982)
41. Kwon S. H., Lee H. K., Kim J. A., Hong S. I., Kim H. C., Jo T. H., et al., Neuroprotective efects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice, Eur. J. Pharmacol., 2010, 649, 210-217
42. Cho E. S., Jang Y. J., Hwang M. K., Kang N. J., Lee K. W., Lee H. J., Attenuation of oxidative neuronal cell death by cofee phenolic phytochemicals, Mutat. Res., 2009, 661, 18-24
43. Ho L., Varghese M., Wang J., Zhao W., Chen F., Knable L. A., et al., Dietary supplementation with decafeinated green cofee improves diet-induced insulin resistance and brain energy metabolism in mice, Nutr. Neurosci., 2012, 15, 37-45
44. Ho L., Qin W., Pompl P. N., Xiang Z., Wang J., Zhao Z., et al., Dieti-nduced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease, FASEB J., 2004, 18, 902-909